Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leiner Early 2001 Supplement Launches Aim To Fill Portfolio Gaps

This article was originally published in The Tan Sheet

Executive Summary

Leiner will introduce private label calcium-containing soft chews, comparable to Mead Johnson's Viactiv Calcium Soft Chews, in January in the top-selling milk chocolate flavor.

You may also be interested in...



Centrum Line Controls Over One-Third Of Multivitamins Category In 2000

Whitehall-Robins' Centrum Performance multivitamin/herbal supplement capped off its first year on the market with sales of $28 mil. and a sixth place ranking among top brands in the multivitamin category in 2000, according to data from Information Resources, Inc. (Chicago).

Centrum Line Controls Over One-Third Of Multivitamins Category In 2000

Whitehall-Robins' Centrum Performance multivitamin/herbal supplement capped off its first year on the market with sales of $28 mil. and a sixth place ranking among top brands in the multivitamin category in 2000, according to data from Information Resources, Inc. (Chicago).

Centrum Line Controls Over One-Third Of Multivitamins Category In 2000

Whitehall-Robins' Centrum Performance multivitamin/herbal supplement capped off its first year on the market with sales of $28 mil. and a sixth place ranking among top brands in the multivitamin category in 2000, according to data from Information Resources, Inc. (Chicago).

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091937

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel